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FIGURE. Microorganisms isolated from patients with nosocomial urinary tract infections. 
care practices, and implementation of 
infection control measures. 
A common exogenous risk factor 
for all of the organisms causing noso-
comial UTIs was catheterization. 
Inadequate infection control mea-
sures comprise another likely con-
tributing factor. Inappropriate discon-
nection of the catheter-collecting tube 
junction can favor infection7 and may 
have been a risk factor in this hospital. 
Exogenous risk factors relat-
ed to Escherichia coli, entero-
cocci, Staphylococcus aureus, and 
Staphylococcus epidermidis nosocomi-
al UTIs and the association between 
infections by these organisms and 
Proteus species and specific patient 
care areas could not be compared 
with prior data because surveillance 
of nosocomial infection has not been 
performed in this hospital on a rou-
tine basis. These results could pro-
vide baseline data for future compar-
isons, perhaps for assessing the 
influence of interventions. 
Contrary to prior reports empha-
sizing only Klebsiella as a more fre-
quent cause of nosocomial UTI among 
diabetic patients,89 diabetes mellitus 
was an endogenous risk factor for 
most pathogens in the current study. 
The relative lack of independent 
risk factors for nosocomial UTIs with 
Serratia marcescens could be due to 
the small number of cases studied. 
Because only four cases of nosocomi-
al UTIs were due to Acinetobacter cal-
coaceticus, a case-control study was 
not conducted for this pathogen. 
The distribution of microorgan-
isms causing nosocomial UTI among 
our patients was similar to those 
from reports from other countries. 
Identification of risk factors for infec-
tion by various organisms may allow 
future risk-adjusted comparisons of 
infection rates. 
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Assessment of a Novel 
Approach to Evaluate the 
Outcome of Endoscope 
Reprocessing 
To the Editor: 
In the April issue of Infection 
Control and Hospital Epidemiology, 
Sciortino et al.1 proposed a novel 
method to detect contamination of 
reprocessed endoscopes. Although 
bioluminescence could qualify as an 
economical method for this purpose, 
the study leaves several questions 
unanswered regarding the validity of 
this test. 
Briefly, a portable luminometer 
system was used to compare 15 
reprocessed endoscopes with micro-
biological culture, the currently 
accepted gold standard. Interpretative 
criteria for bioluminescence were 
established beforehand by comparing 
serial dilutions of bacteria with the 
assay under investigation. A total of 94 
endoscopes were then examined only 
by bioluminescence in different 
stages of reprocessing and declared 
sterile, clean, or contaminated. The 
results showed that some endoscopes 
without bacterial growth had negative 
results on Charm LUMinator-T 
(LUM-T) (Charm Sciences, Inc., 
Maiden, MA) assay; reprocessing 
gradually decreased relative light unit 
(RLU) counts on most, but not all, 
endoscopes; and by bioluminescence, 
few of the reprocessed endoscopes 
could be declared sterile. 
Since the early 1980s, many arti-
cles about bioluminescence have been 
published. The conclusions vary,26 
resulting mainly in the fact that biolu-
minescence has not evolved into a 
standard for validation of endoscope 
reprocessing methods. The current 
study was initiated as part of a broad 
investigation at one center in response 
to inadequate techniques for endo-
scope reprocessing. However, the 
authors claim the evaluation of a test 
as the main objective of their study. 
The interpretative criteria 
derived from serial dilutions of bac-
terial suspensions, as shown in 
Figure 1 of the article (which 
appears on the next page), are suit-
able for the authors' intention, but 
some data are not reported. The 
results shown in the figure do not 
correspond to the numbers reported 
in the text. The lower limits of detec-
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FIGURE. Charm LUMinator-T (Charm Sciences, Inc., Maiden, MA) analysis of adenosine triphosphate 
(ATP) relative light units (RLUs) versus actual colony-forming units or cell numbers for dilutions of cells 
dried on 100-cm2 aluminum foil sheets. Triangle = Candida albicans; diamond = Pseudomonas 
aeruginosa; square = Escherichia coli; and x = blood. 
tion as read in the figure are 106 cells 
for Pseudomonas aeruginosa (vs 105 
in the text) and 102 for blood cells 
(vs 101 in the text). Also, results for 
Staphylococcus aureus, mentioned in 
the Methods section, are not shown 
in the figure. Instead, data for 
Escherichia coli appear. 
The cutoff values for sterile, 
clean, and contaminated are based on 
the results of this comparison only, 
and should be validated before imple-
mentation in clinical practice. With a 
lower limit of detection of 106 cells 
(eg, for E. coli), zero RLUs are used to 
declare an endoscope as being sterile, 
whereas in reality this could translate 
to anywhere between 0 and 105 cells. 
A correlation between cell counts and 
colony-forming units is not reported. 
The authors then compared their non-
standardized and unvalidated test 
with the gold standard (microbiologi-
cal culture) in 15 samples that were 
selected only on the basis of biolumi-
nescence results. 
Comparisons of LUM-T results 
with Gram stain and culture are even 
more difficult to interpret because the 
sampling methods were completely 
different. Whereas sampling for the 
bioluminescence assay focused on the 
shank and the terminal 1 cm of the 
channel (which channel is not speci-
fied, nor is the type of endoscope), 
samples for cultures were taken from 
fluid used for flushing the inside of the 
endoscope. The results of cultures 
from sterile water in which the endo-
scopes were immersed are not report-
ed. A correct validation would have 
performed both tests with the same 
sampling method in a blinded fashion 
on a random or consecutive sample of 
endoscopes and then compared the 
results using simple statistical tests 
for categorical and continuous vari-
ables. Therefore, the reported results 
represent a comparison of an unvali-
dated test method from the outside of 
the endoscope with a validated test 
method from the inside. 
The "statistical analysis" per-
formed to assess the cleaning and dis-
infection process shows only that con-
secutive cleaning, disinfection, and 
ethanol rinse reduced the amount of 
adenosine triphosphate (equaling 
cells) in most of the endoscopes test-
ed. It is restricted to reporting mean 
RLU counts. None of these endo-
scopes were cultured for comparison. 
Furthermore, several state-
ments in the Discussion section of the 
article are misleading. First, the semi-
quantitative relationship between cell 
counts and adenosine triphosphate 
RLUs is a misnomer. Is this a way to 
express the fact that there is no quan-
titative correlation but a mere coinci-
dence of positive results? Second, the 
argument that the lower limit of 
detection might miss skin contamina-
tion is euphemistic. Reprocessing of 
an endoscope with cleaning and high-
level disinfection should lead to an 
endoscope free of vegetative microor-
ganisms regardless of their origin. 
This would be clearly missed by the 
test described. Third, the biolumines-
cence testing contributed in no way to 
the investigative steps described. The 
100-fold greater sensitivity of this test 
compared with cultures is not sup-
ported by any data, and, accordingly, 
an appropriate literature reference is 
missing. No other study using biolu-
minescence to detect bacteria is cited 
in the reference list. 
Bioluminescence has indeed 
been used as an audit tool to evaluate 
the efficacy of a cleaning system. An 
endoscope passing this test may still 
be contaminated. The authors' con-
clusion that "the system provided a 
rapid microbiological outcome moni-
tor for the cleaning and disinfection 
process" may, although neither sup-
ported nor validated by this study, 
lead lawyers, judges, and hospital 
administrators to uncritical, inappro-
priate, and therefore harmful use. 
The results of this study 
do not support the conclusions. 
Bioluminescence may be a surrogate 
marker, and this idea deserves 
publication. However, biolumines-
cence should be validated with the 
gold standard—microbiological cul-
tures—with an appropriate sample 
size (eg, more than 250 endoscope 
cultures from different channels) 
before being recommended for use 
as a monitoring tool. Sensitivity and 
specificity results derived from such 
a study would be greatly welcomed 
by infection control professionals. 
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The authors reply. 
Dr. Tietz and his associates state 
that the values in the figure do not 
correspond with statements in the 
text. In fact, they do. Although the 
lines of the graph may appear to 
reach zero in accordance with the 
statement by Dr. Tietz and his associ-
ates, in actuality, 105 Pseudomonas 
aeruginosa gave 2,135 RLUs, 106 
Escherichia coli gave 1,369 RLUs, 
103 Candida albicans gave 582 RLUs, 
and 10 red blood cells gave 
14,274 RLUs. All were within the 
detectable range of the instrument. In 
addition to the quantitative data listed, 
quantitative studies were also 
performed with Staphylococcus xylo-
sus, Erysipelothrix rhusiopathiae, 
Enterococcus durans, Streptococcus 
bovis, Streptococcus pyogenes, Staphylo-
coccus aureus, and Streptococcus pneu-
moniae. Data from these studies were 
presented to the editor as a note in 
proof, but were omitted from the pub-
lication because they provided no 
additional significance to the data 
given. 
We chose not to mislead readers 
into thinking that the biolumines-
cence assay is an exact quantitative 
measurement of colony-forming 
units. At least in our laboratory, we 
could not demonstrate precise 
quantitative numbers using this assay. 
The results we obtained for RLUs did, 
however, demonstrate approximate 
numbers of organisms on the loga-
rithmic scale that best indicated high 
versus low microbial load. 
The culture of endoscopes in 
this study included brushing the 
internal channels and the exterior 
of the endoscopes to dislodge any 
organisms. All were cultured or 
tested by gene probe technology. 
Therefore, the sampling for cultured 
endoscopes was the same as for the 
LUM-T assay with the exception that 
the entire internal channel was not 
sampled for the LUM-T assay. Five 
endoscopes that had negative results 
on the LUM-T assay were also cul-
tured and had negative results. 
These five endoscopes served as the 
negative control, and if the sterile 
water used to rinse endoscopes had 
been contaminated, cultures would 
have revealed this. Therefore, the 
culture of the sterile water as sug-
gested by Dr. Tietz and his associ-
ates is irrelevant. 
We agree with Dr. Tietz and his 
associates that the cutoff values for 
sterile, clean, and contaminated were 
based on our observations, and we 
stated in the article that "other insti-
tutions may choose to set different 
limits based on their experiences with 
the LUM-T system." 
High-level disinfection of endo-
scopes is a controversial issue. High-
level disinfection does not equal 
sterility. Some argue that endoscopes 
should be rendered sterile and that 
only sterile endoscopes be used for 
patient care. Is this practical in the 
clinical setting? 
Our findings showed that once 
endoscopes were reprocessed, they 
were not maintained in a sterile envi-
ronment but rather a clean environ-
ment. Thus, our discussions with 
physicians indicated that some envi-
ronmental contamination of endo-
scopes does reoccur prior to patient 
use. The level of recolonization then 
becomes a concern and an issue to 
be addressed. At what microbial load 
do we then deem an endoscope 
"improper for reuse?" How do we 
measure that in real time? Microbial 
culture of endoscopes requires days 
to weeks and is impractical. The bio-
luminescence assay can demonstrate 
contamination above that of normal 
skin flora and may prove to be the 
best rapid method available to 
demonstrate this phenomenon. 
We have not stated or implied 
that a negative result on LUM-T assay 
equals sterility. The concept that not a 
single vegetative cell should exist on 
or inside the instrument before patient 
reuse is an idealistic one. We do not 
argue that conceptually sterility is the 
best practice, but rather that it is not 
the current standard. The question 
that then arises is whether it is feasible 
to create such standards. Unless stan-
dards are changed so that high-level 
disinfection imparts sterility and that 
sterility is maintained throughout stor-
age and handling, we cannot ensure 
that infections will not arise from 
reprocessed endoscopes. Therefore, 
the decision to assume that all endo-
scopes are sterile because they have 
been high-level disinfected and to not 
monitor this process is misleading and 
possibly harmful. 
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Epidemic Parenteral 
Exposure to Volatile 
Sulfur-Containing 
Compounds at a 
Hemodialysis Center 
To the Editor: 
In the March issue of Infection 
Control and Hospital Epidemiology, 
Selenic et al. reported that an epidem-
ic became manifest during 30 minutes 
beginning approximately 1 hour after 
reverse osmosis units were returned 
to the treatment loop during dialysis of 
16 patients.1 Their symptoms included 
chills, nausea, vomiting, hypotension, 
hypoxemia, tachypnea, fever, leukope-
nia followed by leukocytosis with a 
profound left shift, toxic granulations, 
and Dohle bodies. Two patients died 
and two had positive blood cultures, 
one for Citrobacter. Some water sam-
ples at the site contained excess endo-
toxin, and others contained excess 
viable aerobic bacteria. 
The authors obtained samples 6 
days after the dialysis center had been 
closed and the reverse osmosis unit 
had been sitting without water circula-
tion. A "sulfur" odor was detected, 
which had been noted only once previ-
ously by an attendant, and the pres-
ence of four sulfur compounds, which 
the authors note may have been gen-
erated by growth of anaerobic bacteria 
in the inactive reverse osmosis unit, 
was detected by gas chromatography 
and mass spectrometry. 
The authors stated that this was 
the first reported hemodialysis out-
break linked to sulfide exposure. 
They reviewed the toxicology of the 
sulfides they detected, given by non-
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